L-deamino-8-d-arginine vasopressin treatment in pregnancy and neonatal outcome: a report of three cases
Three women with neurohypophyseal diabetes insipidus, treated for prolonged periods, including pregnancy, with L-deamino-8-d-arginine vasopressin, gave birth in our hospital. Two of the infants had severe congenital heart disease, one of which was associated with trisomy 21. The third baby, born pre...
Gespeichert in:
| Veröffentlicht in: | American journal of perinatology 1986-07, Vol.3 (3), p.165-167 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 167 |
|---|---|
| container_issue | 3 |
| container_start_page | 165 |
| container_title | American journal of perinatology |
| container_volume | 3 |
| creator | LINDER, N MATOTH, I OHEL, G YOURISH, D TAMIR, I |
| description | Three women with neurohypophyseal diabetes insipidus, treated for prolonged periods, including pregnancy, with L-deamino-8-d-arginine vasopressin, gave birth in our hospital. Two of the infants had severe congenital heart disease, one of which was associated with trisomy 21. The third baby, born prematurely, presented with mild intrauterine growth retardation; at the age of 21 months, the boy had severe failure to thrive, hypotonia, and motor retardation. These three cases raise doubts as to the safety of diabetes insipidus or its treatment in pregnancy. |
| doi_str_mv | 10.1055/s-2007-999859 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_3718635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3718635</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-c4731454899b8e77c10b1c0915f952ce3b4e92ae518f9e785c1f37a34f5457003</originalsourceid><addsrcrecordid>eNo9j0tLAzEUhYMotVaXLoUs3EZzJ5MmcSfFFxTc6LrcydzUkU5mSFKh_94Bi6vDeXDgY-wa5B1Ire-zqKQ0wjlntTthc5DOCmusPmVzaZQWsFRwzi5y_pYSKivtjM2UAbtUes62a9ES9l0chBWtwLTtYheJ_2AexkQ5d5GXRFh6ioVPZgq3EaM_cIwtjzRELLjjw774oacHjjzROKTCh8DLVyLiHjPlS3YWcJfp6qgL9vn89LF6Fev3l7fV41qMoGURvjYKal1b5xpLxniQDXjpQAenK0-qqclVSBpscDRBegjKoKqDrrWRUi3Yzd_vuG96ajdj6npMh80ReOpvjz1mj7uQJpQu_88sVJWqpPoFtTFkEQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>L-deamino-8-d-arginine vasopressin treatment in pregnancy and neonatal outcome: a report of three cases</title><source>MEDLINE</source><source>Thieme Connect Journals</source><creator>LINDER, N ; MATOTH, I ; OHEL, G ; YOURISH, D ; TAMIR, I</creator><creatorcontrib>LINDER, N ; MATOTH, I ; OHEL, G ; YOURISH, D ; TAMIR, I</creatorcontrib><description>Three women with neurohypophyseal diabetes insipidus, treated for prolonged periods, including pregnancy, with L-deamino-8-d-arginine vasopressin, gave birth in our hospital. Two of the infants had severe congenital heart disease, one of which was associated with trisomy 21. The third baby, born prematurely, presented with mild intrauterine growth retardation; at the age of 21 months, the boy had severe failure to thrive, hypotonia, and motor retardation. These three cases raise doubts as to the safety of diabetes insipidus or its treatment in pregnancy.</description><identifier>ISSN: 0735-1631</identifier><identifier>EISSN: 1098-8785</identifier><identifier>DOI: 10.1055/s-2007-999859</identifier><identifier>PMID: 3718635</identifier><identifier>CODEN: AJPEEK</identifier><language>eng</language><publisher>New York, NY: Thieme</publisher><subject>Abnormalities, Drug-Induced - etiology ; Adult ; Biological and medical sciences ; Deamino Arginine Vasopressin - adverse effects ; Diabetes Insipidus - drug therapy ; Drug toxicity and drugs side effects treatment ; Female ; Humans ; Infant, Newborn ; Medical sciences ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Pharmacology. Drug treatments ; Pregnancy ; Pregnancy Complications - drug therapy ; Prenatal Exposure Delayed Effects</subject><ispartof>American journal of perinatology, 1986-07, Vol.3 (3), p.165-167</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8122320$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3718635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LINDER, N</creatorcontrib><creatorcontrib>MATOTH, I</creatorcontrib><creatorcontrib>OHEL, G</creatorcontrib><creatorcontrib>YOURISH, D</creatorcontrib><creatorcontrib>TAMIR, I</creatorcontrib><title>L-deamino-8-d-arginine vasopressin treatment in pregnancy and neonatal outcome: a report of three cases</title><title>American journal of perinatology</title><addtitle>Am J Perinatol</addtitle><description>Three women with neurohypophyseal diabetes insipidus, treated for prolonged periods, including pregnancy, with L-deamino-8-d-arginine vasopressin, gave birth in our hospital. Two of the infants had severe congenital heart disease, one of which was associated with trisomy 21. The third baby, born prematurely, presented with mild intrauterine growth retardation; at the age of 21 months, the boy had severe failure to thrive, hypotonia, and motor retardation. These three cases raise doubts as to the safety of diabetes insipidus or its treatment in pregnancy.</description><subject>Abnormalities, Drug-Induced - etiology</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Deamino Arginine Vasopressin - adverse effects</subject><subject>Diabetes Insipidus - drug therapy</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Medical sciences</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - drug therapy</subject><subject>Prenatal Exposure Delayed Effects</subject><issn>0735-1631</issn><issn>1098-8785</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9j0tLAzEUhYMotVaXLoUs3EZzJ5MmcSfFFxTc6LrcydzUkU5mSFKh_94Bi6vDeXDgY-wa5B1Ire-zqKQ0wjlntTthc5DOCmusPmVzaZQWsFRwzi5y_pYSKivtjM2UAbtUes62a9ES9l0chBWtwLTtYheJ_2AexkQ5d5GXRFh6ioVPZgq3EaM_cIwtjzRELLjjw774oacHjjzROKTCh8DLVyLiHjPlS3YWcJfp6qgL9vn89LF6Fev3l7fV41qMoGURvjYKal1b5xpLxniQDXjpQAenK0-qqclVSBpscDRBegjKoKqDrrWRUi3Yzd_vuG96ajdj6npMh80ReOpvjz1mj7uQJpQu_88sVJWqpPoFtTFkEQ</recordid><startdate>198607</startdate><enddate>198607</enddate><creator>LINDER, N</creator><creator>MATOTH, I</creator><creator>OHEL, G</creator><creator>YOURISH, D</creator><creator>TAMIR, I</creator><general>Thieme</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>198607</creationdate><title>L-deamino-8-d-arginine vasopressin treatment in pregnancy and neonatal outcome: a report of three cases</title><author>LINDER, N ; MATOTH, I ; OHEL, G ; YOURISH, D ; TAMIR, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-c4731454899b8e77c10b1c0915f952ce3b4e92ae518f9e785c1f37a34f5457003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Abnormalities, Drug-Induced - etiology</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Deamino Arginine Vasopressin - adverse effects</topic><topic>Diabetes Insipidus - drug therapy</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Medical sciences</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - drug therapy</topic><topic>Prenatal Exposure Delayed Effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LINDER, N</creatorcontrib><creatorcontrib>MATOTH, I</creatorcontrib><creatorcontrib>OHEL, G</creatorcontrib><creatorcontrib>YOURISH, D</creatorcontrib><creatorcontrib>TAMIR, I</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>American journal of perinatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LINDER, N</au><au>MATOTH, I</au><au>OHEL, G</au><au>YOURISH, D</au><au>TAMIR, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>L-deamino-8-d-arginine vasopressin treatment in pregnancy and neonatal outcome: a report of three cases</atitle><jtitle>American journal of perinatology</jtitle><addtitle>Am J Perinatol</addtitle><date>1986-07</date><risdate>1986</risdate><volume>3</volume><issue>3</issue><spage>165</spage><epage>167</epage><pages>165-167</pages><issn>0735-1631</issn><eissn>1098-8785</eissn><coden>AJPEEK</coden><abstract>Three women with neurohypophyseal diabetes insipidus, treated for prolonged periods, including pregnancy, with L-deamino-8-d-arginine vasopressin, gave birth in our hospital. Two of the infants had severe congenital heart disease, one of which was associated with trisomy 21. The third baby, born prematurely, presented with mild intrauterine growth retardation; at the age of 21 months, the boy had severe failure to thrive, hypotonia, and motor retardation. These three cases raise doubts as to the safety of diabetes insipidus or its treatment in pregnancy.</abstract><cop>New York, NY</cop><pub>Thieme</pub><pmid>3718635</pmid><doi>10.1055/s-2007-999859</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1631 |
| ispartof | American journal of perinatology, 1986-07, Vol.3 (3), p.165-167 |
| issn | 0735-1631 1098-8785 |
| language | eng |
| recordid | cdi_pubmed_primary_3718635 |
| source | MEDLINE; Thieme Connect Journals |
| subjects | Abnormalities, Drug-Induced - etiology Adult Biological and medical sciences Deamino Arginine Vasopressin - adverse effects Diabetes Insipidus - drug therapy Drug toxicity and drugs side effects treatment Female Humans Infant, Newborn Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Pregnancy Pregnancy Complications - drug therapy Prenatal Exposure Delayed Effects |
| title | L-deamino-8-d-arginine vasopressin treatment in pregnancy and neonatal outcome: a report of three cases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T11%3A25%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=L-deamino-8-d-arginine%20vasopressin%20treatment%20in%20pregnancy%20and%20neonatal%20outcome:%20a%20report%20of%20three%20cases&rft.jtitle=American%20journal%20of%20perinatology&rft.au=LINDER,%20N&rft.date=1986-07&rft.volume=3&rft.issue=3&rft.spage=165&rft.epage=167&rft.pages=165-167&rft.issn=0735-1631&rft.eissn=1098-8785&rft.coden=AJPEEK&rft_id=info:doi/10.1055/s-2007-999859&rft_dat=%3Cpubmed_pasca%3E3718635%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3718635&rfr_iscdi=true |